Leak in blood-brain barrier linked to early Alzheimer's

Contrast enhanced MRI found leakages in the blood-brain barrier of people with early Alzheimer’s disease (AD) is associated with cognitive decline.

The study published in Radiology tested 16 patients with early AD and 17 healthy age-matched controls who underwent dynamic contrast material enhanced MRI. The researchers used the Paltak graphical approach to measure blood-brain barrier rate and volume.

Data suggested that the blood-brain barrier leakage rate in images were much higher in patients with AD compared to those without the disease, showing up most in the cerebrum. Patients with AD also had a significantly higher volume of leaking brain tissue in the gray matter, normal-appearing white matter and deep gray matter. 

"Blood-brain barrier leakage means that the brain has lost its protective means, the stability of brain cells is disrupted and the environment in which nerve cells interact becomes ill-conditioned," said study author Walter H. Backes, PhD, from the Maastricht University Medical Center in Maastricht, Netherlands. "These mechanisms could eventually lead to dysfunction in the brain."

The correlation between blood-brain barrier impairment and decline in cognitive performance that the researchers found, suggests that a leak in the blood-brain barrier is part of the early stages of AD and could eventually lead to cognitive decline and dementia.

"For Alzheimer's research, this means that a novel tool has become available to study the contribution of blood-brain barrier impairment in the brain to disease onset and progression in early stages or pre-stages of dementia," said Backes. 

 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.